src='https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-2513966551258002'/> Rightways: Pneumonia Infolinks.com, 2618740 , RESELLER

Pages

Share This

Showing posts with label Pneumonia. Show all posts
Showing posts with label Pneumonia. Show all posts

Saturday, March 8, 2025

Pneumonia now the leading cause of certified deaths in Malaysia

KUALA LUMPUR: Pneumonia has become the leading cause of certified deaths in Malaysia while seasonal influenza remains a global health concern, affecting at least one billion people annually.

According to the Statistics Department, 60.7% of the 196,965 deaths in 2023 were classified as medically certified deaths, while 39.3% were non-medically certified.

As far as certified deaths are concerned, pneumonia is the principal cause, accounting for 18,181 deaths or 15.2%.

Sunway Medical Centre Velocity (SMCV) consultant respiratory and internal medicine physician Dr Nurul Yaqeen Mohd Esa said the rising prevalence of respiratory viruses such as influenza and Covid-19 has made individuals more vulnerable to pneumonia.

She attributed the surge in pneumonia-related deaths to Malaysia’s ageing population, delays in seeking medical care and low vaccination rates.

“Pneumonia is a severe respiratory infection that causes lung inflammation, leading to breathing difficulties, reduced oxygen levels and potential complications that may require hospitalisation or result in death.

“While the elderly are at higher risk, younger individuals with weakened immune systems, chronic illnesses or poor lifestyle habits are also vulnerable,” she said in a statement to Bernama.

She said the rising pneumonia cases among younger individuals in recent years are largely due to exposure to respiratory viruses, smoking and vaping.

She explained that influenza and Covid-19 weaken the body’s defence mechanisms, making individuals more susceptible to bacterial infections that can trigger pneumonia.

“The flu virus damages the protective membranes lining the airways and cilia, tiny hair-like structures that clear mucus, creating a breeding ground for bacteria.

“It spreads through respiratory droplets or contaminated surfaces when an infected person coughs or sneezes,” she said, advising those recovering from the flu to watch for prolonged fever, worsening cough or breathing difficulties as potential signs of pneumonia.

Dr Nurul said as infected individuals could be contagious one day before symptoms appear and up to seven days after symptoms surface, it is important to emphasise the importance of early detection and preventive measures.

Citing recent cases, she noted that Taiwanese actress Barbie Hsu and Chinese actor Liang Youcheng succumbed to pneumonia-related complications following influenza infections, demonstrating how rapidly respiratory illnesses can escalate, even in younger adults.

She urged high-risk individuals to prioritise pneumococcal and influenza vaccinations, which can significantly reduce the severity of pneumonia.

The influenza vaccine lowers hospitalisation rates by 40% to 60% among healthy adults, while the pneumococcal vaccine reduces the risk of severe pneumonia by up to 75% in older adults.

“Annual influenza vaccination is recommended for everyone, while adults over 65 should receive the pneumococcal vaccine with booster doses based on individual risk factors,” she said.

Meanwhile, SMCV consultant emergency physician Dr Lim Fang Jen said pneumonia symptoms, including shortness of breath, chest pain and confusion, are often mistaken for typical respiratory infections, leading to delayed treatment.

“When pneumonia becomes critical, its progression could be swift and devastating. Patients experiencing severe respiratory distress, dangerously low oxygen levels, confusion or altered mental status may need intensive care or mechanical ventilation.

“If left untreated, pneumonia can cause myocarditis (heart muscle inflammation), encephalitis (brain inflammation), myositis or rhabdomyolysis (muscle inflammation or damage), sepsis (a life-threatening inflammatory response to infection) and multi- organ failure.

“Pneumonia can worsen pre- existing conditions, particularly in individuals with diabetes, heart disease or chronic lung conditions, and those with compromised immune systems face an increased risk of prolonged hospitalisation, permanent organ damage or death,” he said.

These insights highlight the urgent need for early detection, proactive prevention and timely intervention to mitigate the potentially fatal consequences of pneumonia.


Related:

Related posts:



Monday, November 25, 2024

JAB AGAINST PNEUMONIA, TIME FOR ANOTHER VAX DRIVE

Stay covered: It’s suggested that a broader respiratory health strategy is needed, including promoting pneumococcal and influenza vaccinations and ensuring early diagnosis and treatment of respiratory infections.


There is a rise in deaths related to pneumonia, which is a highly avoidable disease. It has surpassed heart disease to become Malaysia’s leading cause of death in 2023. Health experts recommend pneumococcal vaccinations for adults and high-risk groups.

Ageing population calls for focus on adult pneumonia, say docs

PETALING JAYA: Malaysia should introduce pneumococcal vaccines for adults and high-risk groups following the steady rise in pneumonia-related deaths, say health experts.

While pneumococcal vaccination is already part of the National Immunisation Programme for children, they said there is no such programme yet for adults, the elderly, and those with chronic conditions.

Federation of Private Medical Practitioners’ Associations Malaysia president Dr Shanmuganathan Ganeson said Malaysia should integrate this vaccine as it has great public health benefits.

“Many countries have successfully reduced pneumonia-related morbidity and mortality by integrating pneumococcal vaccines. Malaysia should follow suit.

ALSO READ: Understanding Malaysia’s No. 1 killer

“It will help reduce hospital admissions by preventing severe pneumonia and invasive diseases, decrease healthcare costs by minimising complications and intensive care needs, and promote herd immunity by lowering bacterial transmission to protect unvaccinated individuals.

“Cost-effectiveness studies in other nations suggest that national-level vaccinations could have a long-term economic benefit alongside improved health outcomes,” he said in an interview yesterday.

Calling pneumonia a “highly avoidable disease”, Dr Shanmuganathan noted a rise in pneumonia-related deaths, particularly in 2021, due to Covid-19.

ALSO READ: Go big to fight pneumonia, says MMA

“Even after recovery, some individuals experienced secondary bacterial infections, further increasing pneumonia risks,” he added.

He pointed out that strained healthcare capacity also delayed treatment for other respiratory conditions.

At the same time, an ageing population and prevalent non-communicable diseases like diabetes and heart disease heightened pneumonia risks.

“The rise of antibiotic-resistant strains like Streptococcus pneumoniae has complicated treatment.

“Also, the lack of widespread adoption of the pneumococcal vaccine, especially among high-risk groups, leaves a significant portion of the population vulnerable,” he said.

Dr Shanmuganathan said the pneumococcal vaccine effectively reduces the risk of severe pneumococcal disease.

He added that the pneumococcal conjugate vaccine (PCV) can prevent up to 80% of invasive diseases in children.

“For the elderly and high-risk groups, the vaccine significantly lowers the risk of complications and death.

“Its efficacy varies depending on the individual health status and the vaccine type – either the PCV or the pneumococcal polysaccharide vaccine (PPSV).

“Importantly, it offers protection against antibiotic-resistant strains of pneumococcus, addressing a growing concern.

“Malaysians, especially high-risk groups, should get the pneumococcal vaccine available in hospitals and clinics.

“This includes children under two, adults over 65, those with chronic diseases and the immunocompromised,” he said, adding that increasing the awareness of the benefits of the vaccine and its availability at most clinics is important.

With pneumonia now the leading cause of death, Dr Shanmuganathan said it is essential to update the Covid-19 vaccination programme, focusing on new variants like XEC and vulnerable populations.

He emphasised that a broader respiratory health strategy is needed, including promoting pneumococcal and influenza vaccinations and ensuring early diagnosis and treatment of respiratory infections.

“Private general practitioners should be kept informed of these developments.

“The Health Ministry must remain proactive, despite diverting staff to address the doctor shortage in clinical sectors,” he said.

Association of Private Hospitals Malaysia president Datuk Dr Kuljit Singh said while Covid-19 infections may have been reduced, influenza cases are rising, with respiratory syncytial virus (RSV) becoming more recognised as a significant infection.

As such, he said the government should consider including pneumococcal vaccines in Malaysia’s national vaccination programme.

The vaccines, he added, should also be made readily available at private medical facilities and selected clinics.

“Such a programme should be introduced as it would help reduce morbidity and mortality, especially in the high-risk population.

“Vaccines should be made widely available to reduce the cost and burden of treating illnesses,” he said.

Dr Kuljit suggested that those in the high-risk group consider getting vaccinated to better protect themselves against pneumonia.

He said private medical centres are currently using the latest vaccine, Vaxneuvance, which helps protect against 15 types of pneumococcus.

The cost of pneumococcal vaccines ranges between RM280 and RM400, depending on the type used.

When asked, Dr Kuljit said the steady rise in pneumonia-related deaths in the past decade could be from the large number of high-risk populations due to the nation’s ageing population and those suffering from non-communicable diseases, which result in compromised immune systems.

He also said the increase in cigarette and e-cigarette smoking could also be a factor in the rise of such cases.

Smoking damages the cilia (tiny hair-like structures) in the respiratory tract that help clear pathogens and debris.

“This dysfunction can lead to a higher risk of respiratory infections, including pneumonia,” he said.

Source link

Related stories:

Understanding Malaysia’s No. 1 killer

Go big to fight pneumonia, says MMA

Pneumonia is top killer in Malaysia for 2023, with over 18,000 fatalities

Related posts:

Keeping the virus at bay; Beware the influenza bug, Get the flu vax to stay active again, Protect your workforce during flu season, businesses urged

 

GIVE SENIORS FREE ANNUAL FLU SHOTS